|
|
||||||||
Departments of 1 Neurology and
4 Internal Medicine, University
Hospital, CH-8091 Zürich, Switzerland;
2 Department of Internal Medicine
III,
To evaluate the pathogenetic role of cerebral
blood flow (CBF) changes occurring before and during the development of
acute mountain sickness (AMS), peak mean middle cerebral artery flow velocities (
) were
assessed by transcranial Doppler sonography in 10 subjects at 490-m
altitude, and during three 12-min periods immediately
(SA1), 3 (SA2), and 6 (SA3) h after decompression to a
simulated altitude of 4,559 m. AMS cerebral scores increased
from 0.16 ± 0.14 at baseline to 0.44 ± 0.31 at SA1, 1.11 ± 0.88 at
SA2
(P < 0.05), and 1.43 ± 1.03 at
SA3
(P < 0.01); correspondingly, three,
seven, and eight subjects had AMS. Absolute and relative
at simulated
altitude, expressed as percentages of low-altitude values
(%
), did not
correlate with AMS cerebral scores. Average
%
remained
unchanged, because %
increased in three and remained unchanged or decreased in seven
subjects at SA2 and SA3. These results suggest that
CBF is not important in the pathogenesis of AMS and shows substantial
interindividual differences during the first hours at simulated altitude.
altitude illness; cerebral hemodynamics; ultrasonics
This article has been cited by other articles:
![]() |
A. Van Osta, J.-J. Moraine, C. Melot, H. Mairbaurl, M. Maggiorini, and R. Naeije Effects of High Altitude Exposure on Cerebral Hemodynamics in Normal Subjects Stroke, March 1, 2005; 36(3): 557 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Roach and P. H. Hackett Frontiers of hypoxia research: acute mountain sickness J. Exp. Biol., March 11, 2002; 204(18): 3161 - 3170. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |